Indian stocks: Visit www.stage2stocks.com →

Endovia Health Sciences, Inc.

Stage 4 · Declining · week 48

As of Oct 22, 2026, Endovia Health Sciences is in Stage 4, the downtrend phase, now in week 48 (since Nov 11, 2025). It closed at $0.15, 98.5% below its 52-week high and below its 200-day average, which is falling.

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and anima… More about the company

$0.15
-2.61% today
$1.7M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is EDVA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 50w
S4 18w
S4 16w
S4 15w
S4 49w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 50w → S1 8w → S4 18w → S1 3w → S4 16w → S1 4w → S4 15w → S1 3w → S4 49w current
Total tracked: 166 weeks across 9 stage runs.

EDVA among Biotechnology544th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…544EDVAStage 4 · wk 483−27.3%
vs 52W High
-98.5%
$0.14 lo$9.80 hi
98.5% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 48
1w13w26w
Week 48, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-86.6%
200 DMA: $1.11 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.07x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-27.3%
3M
-60.4%
6M
-86.3%
YTD
-95.0%
1Y
-98.0%
Scan Membership
Breakout Watch
Latest: 2022-08-02
4 appearances in last 60 days. First seen: 2020-08-14.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 48 · Vol 0.07x
2026-10-21S4
Wk 48 · Vol 0.15x
2026-10-20S4
Wk 48 · Vol 0.11x
2026-10-19S4
Wk 47 · Vol 0.04x
2026-10-16S4
Wk 47 · Vol 0.03x
2026-10-15S4
Wk 47 · Vol 0.07x
2026-10-14S4
Wk 47 · Vol 0.06x
2026-10-13S4
Wk 47 · Vol 0.04x
2026-10-12S4
Wk 46 · Vol 0.06x
2026-10-09S4
Wk 46 · Vol 0.05x
2026-10-08S4
Wk 46 · Vol 0.06x
2026-10-07S4
Wk 46 · Vol 0.04x
Moving averages & range
50 DMA
$0.25
200 DMA
$1.11
52W High
$9.80
52W Low
$0.14
5D Low
$0.14
Resistance levels (recent highs)
20d High
$0.19
60d High
$0.47
120d High
$1.34
250d High
$8.60
Next resistance
+28.9%
to 20d High
Dividend Yield
0.00%
P/B -0.0

Endovia Health Sciences: quick answers

What stage is Endovia Health Sciences in?

As of Oct 22, 2026, Endovia Health Sciences (EDVA) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 11, 2025 and is in week 48. What the four stages mean

Is Endovia Health Sciences in an uptrend?

No. Endovia Health Sciences is in a Stage 4 downtrend. It trades 86.6% below its 200-day average, which is falling.

How far is Endovia Health Sciences from its 52-week high?

Endovia Health Sciences closed at $0.15 on Oct 22, 2026, 98.5% below its 52-week high of $9.80. Its 52-week low is $0.14.

How has Endovia Health Sciences performed over the past year?

As of Oct 22, 2026, Endovia Health Sciences is down 98.0% over the past year and down 95.0% so far in 2026.

Which sector and industry is Endovia Health Sciences in?

Endovia Health Sciences is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. The company is based in Fort Lauderdale, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.